Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Transl Stroke Res. 2013 Feb 1;4(1):3–14. doi: 10.1007/s12975-012-0219-0

Figure 2.

Figure 2

In addition to the STAIR criteria, three additional emphases of preclinical studies of preconditioning are discussed here. These directions of study are required because of differences between neuroprotection and preconditioning. The latter induces stress pathways and exhibits a biphasic temporal window of efficacy.